Management of hidradenitis suppurativa in pregnancy - 18/04/17
Abstract |
Hidradenitis suppurativa is a debilitating inflammatory skin disease with a chronic course and often disappointing response to treatment. Though a minority of persons (20%) reports symptom remission during pregnancy, the vast majority experiences no relief (72%), and few experience clinical deterioration (8%). Disease flares are also observed post-partum. The pathophysiological basis for pregnancy-associated fluctuations in clinical status is currently unknown. Because most women with HS require ongoing management throughout pregnancy, it is important to evaluate the suitability and safety of current treatment options for pregnant women. The following review will outline current management strategies for HS and their compatibility with pregnancy and lactation.
Le texte complet de cet article est disponible en PDF.Key words : hidradenitis suppurativa, inflammation, inflammatory skin disease, lactation, pregnancy, post-partum
Abbreviations used : HS, IL, Nd:YAG, NRT, NSAID, TNF
Plan
Funding source: None. |
|
Conflicts of interest: None declared. |
Vol 76 - N° 5
P. 979-989 - mai 2017 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?